These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7693562)

  • 1. [Acquirement of drug resistance and angiogenesis in tumors].
    Kuwano M
    Fukuoka Igaku Zasshi; 1993 Sep; 84(9):377-82. PubMed ID: 7693562
    [No Abstract]   [Full Text] [Related]  

  • 2. [Neovascularization of tumors. New therapeutic possibilities].
    Lund EL; Kristjansen PE
    Ugeskr Laeger; 1999 May; 161(20):2929-33. PubMed ID: 10354776
    [No Abstract]   [Full Text] [Related]  

  • 3. [Significance of vascular endothelial growth factor--VEGF--in tumor angiogenesis. Therapeutic possibilities in solid tumors].
    Werther K; Nielsen HJ
    Ugeskr Laeger; 2000 Sep; 162(37):4916-20. PubMed ID: 11002739
    [No Abstract]   [Full Text] [Related]  

  • 4. Anticancer drug targets: approaching angiogenesis.
    Keshet E; Ben-Sasson SA
    J Clin Invest; 1999 Dec; 104(11):1497-501. PubMed ID: 10587512
    [No Abstract]   [Full Text] [Related]  

  • 5. Vascular endothelium in cancer.
    Nikitenko LL
    Cell Tissue Res; 2009 Jan; 335(1):223-40. PubMed ID: 19015885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhibition of tumor angiogenesis as a cancer treatment].
    Verheul HM; Bom JB; Hoekman K; Pinedo HM
    Ned Tijdschr Geneeskd; 1999 Jul; 143(30):1549-55. PubMed ID: 10443279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous inhibitors of angiogenesis.
    Folkman J
    Harvey Lect; 1996-1997; 92():65-82. PubMed ID: 15372744
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular heterogeneity of tumor endothelium.
    Aird WC
    Cell Tissue Res; 2009 Jan; 335(1):271-81. PubMed ID: 18726119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chapter 8. Proteomic mapping of the vascular endothelium in vivo for vascular targeting.
    Griffin NM; Schnitzer JE
    Methods Enzymol; 2008; 445():177-208. PubMed ID: 19022060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapies.
    Shojaei F; Ferrara N
    Drug Resist Updat; 2008 Dec; 11(6):219-30. PubMed ID: 18948057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelium summary statement III: Cancer prevention and control.
    Reed E; Seffrin J; Giavazzi R; van Hinsbergh V; Madeddu P
    Vascul Pharmacol; 2007 May; 46(5):321-3. PubMed ID: 17234459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galectins in the tumor endothelium: opportunities for combined cancer therapy.
    Thijssen VL; Poirier F; Baum LG; Griffioen AW
    Blood; 2007 Oct; 110(8):2819-27. PubMed ID: 17591944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenesis: the unifying concept in cancer?
    Saphir A
    J Natl Cancer Inst; 1997 Nov; 89(22):1658-9. PubMed ID: 9390530
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of angiogenesis in drug resistance.
    Mattern J
    Anticancer Res; 2001; 21(6B):4265-70. PubMed ID: 11908680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metronomic chemotherapy: teaching old drugs new tricks?
    Vogelzang N
    Clin Adv Hematol Oncol; 2004 Jul; 2(7):432-3. PubMed ID: 16163217
    [No Abstract]   [Full Text] [Related]  

  • 16. Advances in the use of angiogenesis inhibitors in cancer.
    Pinedo HM
    Cancer J; 2001; 7 Suppl 3():S107-8. PubMed ID: 11779080
    [No Abstract]   [Full Text] [Related]  

  • 17. Antiangiogenic therapy at a crossroads: clinical trial results and future directions.
    Ellis LM
    J Clin Oncol; 2003 Dec; 21(23 Suppl):281s-283s. PubMed ID: 14645411
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of angiogenesis in the treatment of tumors.
    Ostrowski K; Kinsner A
    Arch Immunol Ther Exp (Warsz); 2001; 49(1):27-31. PubMed ID: 11266087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Angiogenesis as a target for antitumor actions].
    Ushmorov AG; Aleksandrov VA
    Vopr Onkol; 1989; 35(3):263-70. PubMed ID: 2468258
    [No Abstract]   [Full Text] [Related]  

  • 20. [Anti-angiogenesis: a new concept in therapy of solid malignancies?].
    Schweigerer L
    Med Klin (Munich); 1995 Dec; 90(12):709-12. PubMed ID: 8583988
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.